Concepedia

Steve Perry

SP

Statistics

Publications

17

Citations

925

H-Index

14

Active since

2011

Affiliations

University of California, Santa Cruz(Current)

National Institutes of Health

National Center for Advancing Translational Sciences

University of California, San Francisco

University of Michigan

Steve Perry is an author at University of California, Santa Cruz specializing in pharmacology, medicinal chemistry, and drug discovery.

ORCID

Publications per year

2011–2023

17

Publications

17

N‐acetylcysteine targets 5 lipoxygenase‐derived, toxic lipids and can synergize with prostaglandin E <sub>2</sub> to inhibit ferroptosis and improve outcomes following hemorrhagic stroke in mice

Saravanan S. Karuppagounder, Lauren Alin, Yingxin Chen et al. · Annals of Neurology · 2018 · 294 citations · Full text

, , +17

Potent and Selective Inhibitors of Human Reticulocyte 12/15-Lipoxygenase as Anti-Stroke Therapies

Ganesha Rai, Netra Joshi, Joo Eun Jung et al. · Journal of Medicinal Chemistry · 2014 · 95 citations · Full text

, , +14

Synthesis and Structure–Activity Relationship Studies of 4-((2-Hydroxy-3-methoxybenzyl)amino)benzenesulfonamide Derivatives as Potent and Selective Inhibitors of 12-Lipoxygenase

Diane K. Luci, J. Brian Jameson, Adam Yasgar et al. · Journal of Medicinal Chemistry · 2014 · 86 citations · Full text

, , +13

Discovery of Potent and Selective Inhibitors of Human Platelet-Type 12- Lipoxygenase

Victor Kenyon, Ganesha Rai, Ajit Jadhav et al. · Journal of Medicinal Chemistry · 2011 · 69 citations · Full text

, , +15

An extracellular biochemical screen reveals that FLRTs and Unc5s mediate neuronal subtype recognition in the retina

Jasper J Visser, Yolanda Cheng, Steve Perry et al. · eLife · 2015 · 60 citations · Full text

, , +16

1–5 of 17